MLKL promotes cellular differentiation in myeloid leukemia by facilitating the 
release of G-CSF

Wang, Xin; Ros, Uris; Agrawal, Deepti; Keller, Eva C.; Slotta-Huspenina, Julia; Dill, Veronika; Shen, Bo; Shi, Run; Herold, Tobias; Belka, Claus; Mishra, Ritu; Bassermann, Florian; Garcia Saez, Ana J.; Jost, Philipp J.

doi:10.1038/s41418-021-00826-8

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

s41418-021-00811-1.pdf
(Any fulltext), 4MB

s41418-021-00826-8.pdf
(Any fulltext), 365KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Wang, X., Ros, U., Agrawal, D., Keller, E. C., Slotta-Huspenina, J., Dill, V., et al. (2022). MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF. Cell Death and Differentiation, 28, 3235-3250. doi:10.1038/s41418-021-00826-8.

Cite as: https://hdl.handle.net/21.11116/0000-000E-1045-2

Abstract

The blockade of cellular differentiation represents a hallmark of acute myeloid leukemia (AML), which is largely attributed to the dysfunction of lineage-specific transcription factors controlling cellular differentiation. However, alternative mechanisms of cellular differentiation programs in AML remain largely unexplored. Here we report that mixed lineage kinase domain-like protein (MLKL) contributes to the cellular differentiation of transformed hematopoietic progenitor cells in AML. Using gene-targeted mice, we show that MLKL facilitates the release of granulocyte colony-stimulating factor (G-CSF) by controlling membrane permeabilization in leukemic cells. Mlkl-/- hematopoietic stem and progenitor cells released reduced amounts of G-CSF while retaining their capacity for CSF3 (G-CSF) mRNA expression, G-CSF protein translation, and G-CSF receptor signaling. MLKL associates with early endosomes and controls G-CSF release from intracellular storage by plasma membrane pore formation, whereas cell death remained unaffected by loss of MLKL. Of note, MLKL expression was significantly reduced in AML patients, specifically in those with a poor-risk AML subtype. Our data provide evidence that MLKL controls myeloid differentiation in AML by controlling the release of G-CSF from leukemic progenitor cells.